|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_NewBusinessRelationAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_NatureOfTheOtherPartyWithWhichNewBusinessRelationWillStart|
|
|
Tedarikçi (Supplier)
|
|||||||
|
oda_NameSurnameOrCompanyTitleOfCustomerOrSupplier|
|
|
BALT INTERNATIONAL SAS
|
|||||||
|
oda_IfExistsShareOfCustomerOrSupplierInNetSalesOrCostOfGoodsSoldOnLatestDisclosedProfitOrLossAndOtherComprehensiveIncomeStatementOfCompany|
|
|
0
|
|||||||
|
oda_IfExistsShareOfCustomerOrSupplierInTradeReceivablesOrDebtsOnLatestDisclosedStatementofFinancialPositionOfCompany|
|
|
0
|
|||||||
|
oda_ExpectedStartingDateOfNewBusinessRelation|
|
|
25/11/2025
|
|||||||
|
oda_IfExistSignificantProvisionsOfTheContractTextBlock|
|
|
Summarized below.
|
|||||||
|
oda_ImpactOfNewBusinessRelationOnCompanyActivities|
|
|
Positive impact is expected.
|
|||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
-Unofficial Translation- An exclusive distributorship agreement by 3-years (Three) was signed between Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. (GEN) and France-based Balt International Sas (Balt). According to this agreement, GEN will be the exclusive authority for the supply and distribution activities in Turkey of various medical devices developed and manufactured by Balt and used in the fields of neurovascular and interventional radiology. The agreement is expected to contribute between EUR 15.000.000 and EUR 16.000.000 to GEN's sales in 2026.
|
||||||||